Biodesix acquires Integrated Diagnostics
Molecular diagnostics firm Biodesix has expanded its lung franchise with the acquisition of Seattle-based Integrated Diagnostics (Indi).
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jul 18
Molecular diagnostics firm Biodesix has expanded its lung franchise with the acquisition of Seattle-based Integrated Diagnostics (Indi).
09 Jul 18
3N Diagnostics has entered into an exclusive distribution agreement with Bio-Optica Milan.
02 Jul 18
Swiss drug-maker Novartis is planning to spin off its eye care division Alcon into a standalone company, which…
20 Jun 18
Roche has agreed to acquire remaining shares in Foundation Medicine (FMI), a US molecular and genomic analysis company,…